Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Fluorescein FITC-labeled antibody method

Page View:

Immunofluorescence technology combines fluorescein, such as fluorescein isothiocyanate (FITC), with the corresponding antibody (or antigen) in a chemical way. It combines the fluorescent-labeled antibody (or antigen) with the corresponding antigen in the specimen to form a fluorescent-labeled antibody -Antigen complex observed with a fluorescence microscope. The presence of fluorescence under the microscope indicates the presence of an antigen-antibody complex. The presence of another unknown antigen (or antibody) can be inferred based on the known antibody (or antigen).

Fluorescein FITC-labeled antibody method.webp

Fluorescein FITC-labeled antibody method

Medicilon's antibody development technical service discount covers the full line of ADA antibody development technical services and druggable antibody development technical services. The 20% off discount applies to the completion of ADA rabbit polyclonal antibody development, ADA mouse hybridoma monoclonal antibody development, phage display rabbit monoclonal antibody development services, mouse monoclonal antibody development technical services, mouse/rabbit single B cell antibody development technical services, etc.

Fluorescein FITC-labeled antibody technology principle

  1. Direct immunofluorescence method “Direct immunofluorescence method uses specific antibodies labeled with fluorescent pigments to bind to corresponding antigens to identify unknown antigens directly. This method has the advantages of simple operation, short duration, and high specificity, but it also has disadvantages, such as the inability to detect antibodies and poor sensitivity.

  2. Indirect immunofluorescence method “Indirect immunofluorescence method uses fluorescein-labeled anti-globulin antibody. After the antibody binds to the corresponding antigen, the fluorescent-labeled anti-globulin antibody interacts with the bound antibody, thereby inferring the presence of the antigen or antibody. Indirect fluorescence technology can detect unknown antibodies with known antigens and novel antigens with known antibodies.

Now take the detection of virus antibodies (IgG) as an example.

When FITC reacts with an antibody protein in an alkaline solution, the r amino group of lysine on the protein is combined with the thiocarbamide bond of fluorescein to form FITC-protein conjugates, namely fluorescent antibodies or fluorescent conjugates. 86 lysine residues in an IgG molecule generally can bind 15-20 at most, and an IgG molecule can bind 2-8 molecules of FITC. The reaction formula is as follows:

FITC-N=C=S + N-H2-Protein → FITC-NS-C-N-H2-Protein

The Marshall (1958) method is commonly used to label fluorescent antibodies. The labeling method of Chadwick et al. or the dialysis labeling method of Clark et al. (1963) can also be used according to conditions.

Marshall method

(1) Material

Antibody globulin solution, 0.5mol/L (pH9.0) carbonate buffer, sterile physiological saline, fluorescein isothiocyanate, 1% thimerosal aqueous solution, 50ml small beaker, 4℃ refrigerator, electromagnetic stirrer, Dialysis bag, glass rod, 0.01mol/LPBS with pH 7.2 or 3.0, etc.

(2) Methods and steps

①Preparation of antibody Take a proper amount of globulin solution of known concentration in a beaker and add human saline and carbonate buffer to make the final immunoglobulin concentration 20mg/ml. The carbonate buffer capacity is the total amount of 1/10, mix well, and put the burning ball on the electromagnetic stirrer (the speed is appropriate to avoid foam) for 5-10min.

② Preparation of fluorescein According to the total amount of protein to be labeled, add 0.01 mg of fluorescent pigment per mg of immunoglobulin and accurately weigh the required fluorescein isothiocyanate powder with an analytical balance. The following formula can also be used to calculate the amount of immunoglobulin and fluorescein, and the amount of buffer to be added can also be calculated.

a. Protein solution: content Amg/m1; volume Bml.

b. Total protein amount (AXB)=Crag.

c. C/20~C/10=Dmg (if the protein content is lower than 20mg/ml, use C/10; if it is higher than 20mg/ml, use C/20).

d. The amount of fluorescein FITC: (1/50~2/100) XC=Emg.

e. It is 0.5 mol/L (pH 9.5) carbonate buffer solution D/10=Fml.

f. The amount of PBS D-(B+F)=Gml.

Note: A is the protein content, mg/ml; B is the volume of the protein solution; C is the total protein, mg; D is a constant, mg; vivacious is the amount of fluorescein, mg; F is the volume of carbonate buffer, Ml; G is the volume of PBS, ml.

③Combine (or label) Gradually add the weighed fluorescent pigment into the globulin solution while stirring; avoid sticking the fluorescein to the wall of the flask (approximately within 5-10 minutes); after adding, continue to go for 12h in the dark about. During the crucial period, the protein solution should be kept at about four °C, so move the beaker and stirrer into a four °C refrigerator.

④After dialysis and binding, centrifuge the labeled globulin solution (2500r/min) for 20rains to remove a small amount of sediment, put it into a dialysis bag, and then place it in a beaker, dialyzed with pH 8.0 buffered saline (0~4 ~C) Overnight.

⑤Passing the column Take the dialysis overnight marker, pass it through Sephadex G-25 or G-50 column, separate free fluorescein, and collect the labeled fluorescent antibody for identification. Eluent: 0.01mol/L phosphate buffer (pH 7.2); filtration volume: 12ml labeled global protein solution (not dialyzed before filtration); collection volume: 20ml (diluted by about 1.7 times).

Chadwick method

(1) Reagents and materials

Antibody globulin solution, fluorescein isothiocyanate, 3% sodium carbonate aqueous solution, 0.01mol/L pH8.0PBS, 1% thimerosal, centrifuge and centrifuge tube, beaker (25ml) stirrer, sterile straw, sterile Pipette, capillary dropper, beaker (500ml) dialysis bag, etc.

(2) Methods and steps

① Antibody preparation Dilute the globulin solution to a concentration of 30-40 mg/ml with pH 8.0 phosphate buffered saline at o~4~C, put it in a 25ml beaker, and put it in an ice tank.

② Preparation of Fluorescent Pigment Calculated by adding fluorescein 0.01rug per mg of immunoglobulin, weighing the required fluorescein, and dissolving it with 3% sodium carbonate aqueous solution.

③Mix the prepared antibody and the fluorescent pigment solution in equal amounts, stir thoroughly and combine in a refrigerator at o~4~C (preferably keep stirring on a magnetic stirrer) for 18~24h.

④The dialysis and column chromatography methods are the same as the Marshall method.

Related Articles:

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials

Medicilon assisted Bio-Thera's bispecific neutralizing antibody drug for injection BAT2022 for the treatment of new coronary pneumonia was approved for clinical use

Relevant newsRelevant news